株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

H1N1ワクチンの世界市場

H1N1 Vaccines

発行 Global Industry Analysts, Inc. 商品コード 121144
出版日 ページ情報 英文 76 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
H1N1ワクチンの世界市場 H1N1 Vaccines
出版日: 2019年10月01日 ページ情報: 英文 76 Pages
概要

当レポートでは、世界のH1N1ワクチン市場について調査し、今後の市場動向予測、製品概要、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
    • 世界市場における企業シェア
    • 世界のH1N1ワクチン市場における企業シェアのシナリオ
  • 主要企業
  • 市場の動向と発展因子
  • 世界市場の見通し

第3章 市場分析

  • 地域別市場の分析
    • 米国
    • 日本
    • カナダ
    • 中国
    • フランス
    • 欧州
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
    • アジア太平洋地域
    • オーストラリア
    • インド
    • 韓国
    • その他アジア太平洋地域
    • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
    • 中東
    • イラン
    • イスラエル
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東
    • アフリカ

第4章 競合企業

  • ABBOTT LABORATORIES
  • BAXTER INTERNATIONAL, INC.
  • CIPLA
  • GLAXOSMITHKLINE PLC
  • HUALAN BIOLOGICAL ENGINEERING, INC.
  • MERCK & CO., INC.
  • 田辺三菱製薬
  • SANOFI
  • SINOVAC BIOTECH LTD.
  • PFIZER

第5章 調査資料

目次
Product Code: MCP-6274

H1N1 Vaccines market worldwide is projected to grow by US$1.7 Billion, driven by a compounded growth of 4.9%. H1N1 Vaccines, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$6 Billion by the year 2025, H1N1 Vaccines will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$59.7 Million to the region's size and clout in the next 5 to 6 years. Over US$49.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, H1N1 Vaccines will reach a market size of US$351.7 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.8% over the next couple of years and add approximately US$498.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Abbott Laboratories, Inc.; Baxter International, Inc.; Cipla Ltd.; GlaxoSmithKline PLC; Hualan Biological Engineering, Inc.; Merck & Co., Inc.; Mitsubishi Tanabe Pharma Corporation; Pfizer, Inc.; Sanofi; Sinovac Biotech Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • H1N1 Vaccines Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: H1N1 Vaccines Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: H1N1 Vaccines Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • TABLE 3: United States H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025
  • JAPAN
    • TABLE 4: Japanese Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • CANADA
    • TABLE 5: Canadian H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018 to 2025
  • CHINA
    • TABLE 6: Chinese H1N1 Vaccines Market Growth Prospects in US$ Million for the Period 2018-2025
  • FRANCE
    • TABLE 7: H1N1 Vaccines Market in France: Estimates and Projections in US$ Million for the Period 2018-2025
  • EUROPE
    • Market Facts & Figures
    • TABLE 8: European H1N1 Vaccines Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 9: European H1N1 Vaccines Market Share Shift by Region/Country: 2019 VS 2025
  • GERMANY
    • TABLE 10: H1N1 Vaccines Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • ITALY
    • TABLE 11: Italian H1N1 Vaccines Market Growth Prospects in US$ Million for the Period 2018-2025
  • UNITED KINGDOM
    • TABLE 12: United Kingdom Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • SPAIN
    • TABLE 13: Spanish H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018 to 2025
  • RUSSIA
    • TABLE 14: Russian H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025
  • REST OF EUROPE
    • TABLE 15: Rest of Europe H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018-2025
  • ASIA-PACIFIC
    • TABLE 16: Asia-Pacific H1N1 Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 17: Asia-Pacific H1N1 Vaccines Market Share Analysis by Region/Country: 2019 VS 2025
  • AUSTRALIA
    • TABLE 18: H1N1 Vaccines Market in Australia: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • INDIA
    • TABLE 19: Indian H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018 to 2025
  • SOUTH KOREA
    • TABLE 20: H1N1 Vaccines Market in South Korea: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • REST OF ASIA-PACIFIC
    • TABLE 21: Rest of Asia-Pacific Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • LATIN AMERICA
    • TABLE 22: Latin American H1N1 Vaccines Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 23: Latin American H1N1 Vaccines Market Percentage Breakdown of Sales by Region/Country: 2019 and 2025
  • ARGENTINA
    • TABLE 24: Argentinean H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018-2025
  • BRAZIL
    • TABLE 25: H1N1 Vaccines Market in Brazil: Estimates and Projections in US$ Million for the Period 2018-2025
  • MEXICO
    • TABLE 26: H1N1 Vaccines Market in Mexico: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • REST OF LATIN AMERICA
    • TABLE 27: Rest of Latin America H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025
  • MIDDLE EAST
    • TABLE 28: The Middle East H1N1 Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 29: The Middle East H1N1 Vaccines Market Share Breakdown by Region/Country: 2019 and 2025
  • IRAN
    • TABLE 30: Iranian Market for H1N1 Vaccines: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • ISRAEL
    • TABLE 31: Israeli H1N1 Vaccines Market Estimates and Forecasts in US$ Million: 2018-2025
  • SAUDI ARABIA
    • TABLE 32: Saudi Arabian H1N1 Vaccines Market Growth Prospects in US$ Million for the Period 2018-2025
  • UNITED ARAB EMIRATES
    • TABLE 33: H1N1 Vaccines Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • REST OF MIDDLE EAST
    • TABLE 34: H1N1 Vaccines Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • AFRICA
    • TABLE 35: African H1N1 Vaccines Market Estimates and Projections in US$ Million: 2018 to 2025

IV. COMPETITION

  • ABBOTT LABORATORIES
  • BAXTER INTERNATIONAL, INC.
  • CIPLA
  • GLAXOSMITHKLINE PLC
  • HUALAN BIOLOGICAL ENGINEERING, INC.
  • MERCK & CO., INC.
  • MITSUBISHI TANABE PHARMA CORPORATION
  • SANOFI
  • SINOVAC BIOTECH LTD.
  • PFIZER

V. CURATED RESEARCH

Back to Top